Labcorp received FDA clearance for its blood-based Alzheimer's disease test to help identify amyloid pathology.
Published
Signal category
Legal & Regulatory
Quote
“With FDA clearance of Labcorp's blood-based test to help identify amyloid pathology”
— Dan Jacob|Labcorp team
Company
Labcorp
In Pursuit of Answers
- Industry
- Hospitals and Health Care
- Location
- Burlington, US
- Company size
- 43,268 employees
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about Labcorp (NYSE: LH) at www.labcorp.com.